MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, Ronald B., Berg, Daniela, Stern, Matthew, Poewe, Werner, Olanow, C. Warren, Oertel, Wolfgang, Obeso, José, Marek, Kenneth +10 more·2015·Movement Disorders

Cited by (1,019)

Items 301–400 of 1,019

  1. Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease
    Shishuang Cui, Juanjuan Du, Rao Fu, Yiqi Lin, Pei Huang, Yachao He, Chao Gao, Hua-Long Wang, Shengdi Chen · 2017 · BMC Geriatrics
  2. Alpha-Synuclein in Peripheral Tissues in Parkinson’s Disease
    Lingyan Ma, Gen-Liang Liu, Dongxu Wang, Meimei Zhang, Wenyi Kou, Tao Feng · 2019 · ACS Chemical Neuroscience
  3. Proposal for a Biologic Staging System of Parkinson’s Disease
    Lana M. Chahine, Kalpana Merchant, Andrew D. Siderowf, Todd Sherer, Caroline M. Tanner, KENNETH L. MAREK, Tanya Simuni · 2023 · Journal of Parkinson s Disease
  4. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease
    Tomislav Milekovic, Eduardo Martin Moraud, Nicolò Macellari, Charlotte Moerman, Flavio Raschellà, Shiqi Sun, Matthew G. Perich, Camille Varescon, Robin Demesmaeker, Alice Bruel et al. · 2023 · Nature Medicine
  5. Gastrointestinal Dysfunction in Parkinson’s Disease
    Casper Skjærbæk, Karoline Knudsen, Jacob Horsager, Per Borghammer · 2021 · Journal of Clinical Medicine
  6. Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
    Anna Santaella, H. Bea Kuiperij, Anouke van Rumund, Rianne A.J. Esselink, Alain J. van Gool, Bastiaan R. Bloem, Marcel M. Verbeek · 2020 · BMC Neurology
  7. Expiratory Muscle Strength Training for Therapy of Pharyngeal Dysphagia in Parkinson's Disease
    Inga Claus, Paul Muhle, Judith Czechowski, Sigrid Ahring, Bendix Labeit, Sonja Suntrup‐Krueger, Heinz Wiendl, Rainer Dziewas, Tobias Warnecke · 2021 · Movement Disorders
  8. The Signaling and Pharmacology of the Dopamine D1 Receptor
    Jace Jones-Tabah, Hanan Mohammad, Emma Paulus, Paul B. S. Clarke, Terence E. Hébert · 2022 · Frontiers in Cellular Neuroscience
  9. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease
    Isabel Ortuño‐Lizarán, Gema Esquiva, Thomas G. Beach, Geidy E. Serrano, Charles H. Adler, Pedro Lax, Nicolás Cuenca · 2018 · Acta Neuropathologica Communications
  10. Lewy body disease or diseases with Lewy bodies?
    Kateřina Menšíková, Radoslav Matěj, Carlo Colosimo, Raymond L. Rosales, Lucie Tučková, Jiří Ehrmann, Dominik Hraboš, Kristýna Kolaříková, Radek Vodička, Radek Vrtěl et al. · 2022 · npj Parkinson s Disease
  11. Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
    Bart de Laat, Jocelyn Hoye, Gelsina Stanley, Michelle Hespeler, Jennifer Ligi, Varsha Mohan, Dustin Wooten, Xiaomeng Zhang, Thanh Duc Nguyen, Jose Key et al. · 2024 · npj Parkinson s Disease
  12. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
    Yihua Ma, Carly M. Farris, Sandrina Weber, Sebastian Schade, Hieu Nguyen, Alexandra Pérez‐Soriano, Darly Milena Giraldo, Manel Fernández, Marta Soto, Ana Cámara et al. · 2024 · The Lancet Neurology
  13. Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson’s disease
    Jia Zhang, Chuanying Xu, Jun Liu · 2017 · BMC Neurology
  14. Tau and MAPT genetics in tauopathies and synucleinopathies
    Etienne Léveillé, Owen A. Ross, Ziv Gan‐Or · 2021 · Parkinsonism & Related Disorders
  15. Electroacupuncture for motor dysfunction and constipation in patients with Parkinson's disease: a randomised controlled multi-centre trial
    Kunshan Li, Shifen Xu, Ruiping Wang, Xuan Zou, Huirong Liu, Chunhai Fan, Jing Li, Guona Li, Yiwen Wu, Xiao‐peng Ma et al. · 2023 · EClinicalMedicine
  16. Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition
    Jennifer Wojtala, Ines Ann Heber, Petra Neuser, Julia Heller, Elke Kalbe, Sarah Rehberg, Alexander Storch, Katharina Linse, Christine B. Schneider, Susanne Gräber et al. · 2018 · Journal of Neurology Neurosurgery & Psychiatry
  17. Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity <i>via</i> AMPK/SOD2 Pathway
    Xie, Zhenchao, Zhang, Mahui, Luo, Yuqi, Jin, Dana, Guo, Xingfang, Yang, Wanlin, Zheng, Jialing, Zhang, Hongfei, Zhang, Lu, Deng, Chao et al. · 2023 · Aging and disease
  18. Prevention of progression in Parkinson’s disease
    Jan Aaseth, Petr Dušek, Per M. Roos · 2018 · BioMetals
  19. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus
    Yuanfang Li, Changpeng Wang, Jian Wang, Ying Zhou, Fang Ye, Yong Zhang, Xiaoqin Cheng, Zhen Huang, Kai Liu, Guoqiang Fei et al. · 2019 · Movement Disorders
  20. The noradrenergic subtype of Parkinson disease: from animal models to clinical practice
    К. Ray Chaudhuri, Valentina Leta, Kirsty Bannister, David James Brooks, Per Svenningsson · 2023 · Nature Reviews Neurology
  21. A machine learning method to process voice samples for identification of Parkinson’s disease
    Anu Iyer, Aaron S. Kemp, Yasir Rahmatallah, Lakshmi Pillai, Aliyah Glover, Fred Prior, Linda J. Larson‐Prior, Tuhin Virmani · 2023 · Scientific Reports
  22. 123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies
    Satoshi Orimo, Makiko Yogo, Tomohiko Nakamura, Masahiko Suzuki, Hirohisa Watanabe · 2016 · Ageing Research Reviews
  23. MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse model
    Qiang Sun, Songlin Wang, Jun Chen, Hongxia Cai, Wei Huang, Yueliang Zhang, Lei Wang, Yu Xing · 2019 · Journal of Cellular Physiology
  24. Methamphetamine use and future risk for Parkinson’s disease: Evidence and clinical implications
    Julia Lappin, Shane G Darke, Michael Farrell · 2018 · Drug and Alcohol Dependence
  25. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
    Dahua Fan, Liping Liu, Zhengzhi Wu, Meiqun Cao · 2018 · Current Neuropharmacology
  26. High-Resolution Motor State Detection in Parkinson’s Disease Using Convolutional Neural Networks
    Franz Pfister, Terry Taewoong Um, Daniel Pichler, Jann Goschenhofer, Kian Abedinpour, M. Lang, Satoshi Endo, Andrés Ceballos-Baumann, Sandra Hirche, Bernd Bischl et al. · 2020 · Scientific Reports
  27. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease
    Yuto Uchida, Hirohito Kan, Keita Sakurai, Shohei Inui, Susumu S. Kobayashi, Yoshihiro Akagawa, K Shibuya, Yoshino Ueki, Noriyuki Matsukawa · 2020 · Movement Disorders
  28. Accelerated Transcranial Ultrasound Neuromodulation in Parkinson's Disease: A Pilot Study
    Nardin Samuel, Mandy Yi Rong Ding, Can Sarica, Ghazaleh Darmani, Irene E. Harmsen, Talyta Cortez Grippe, Xingyu Chen, Andrew Yang, Negar Nasrkhani, Ke Zeng et al. · 2023 · Movement Disorders
  29. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine
    Okamoto, Luis E., Diedrich, André, Baudenbacher, Franz J., Harder, René, Whitfield, Jonathan S., Iqbal, Fahad, Gamboa, Alfredo, Shibao, Cyndya A., Black, Bonnie K., Raj, Satish R. et al. · 2016 · Hypertension
  30. Assessment of Motor Impairments in Early Untreated Parkinson's Disease Patients: The Wearable Electronics Impact
    Mariachiara Ricci, Giulia Di Lazzaro, Antonio Pisani, Nicola Biagio Mercuri, Franco Giannini, Giovanni Saggio · 2019 · IEEE Journal of Biomedical and Health Informatics
  31. Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
    Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, Piero Coleschi, Laura Maria Raglione, Paola Vanni, Silvia Ramat et al. · 2020 · Journal of Neurology
  32. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
    Aaron D. Thome, Farah Atassi, Jinghong Wang, Alireza Faridar, Weihua Zhao, Jason R. Thonhoff, David R. Beers, Eugene C. Lai, Stanley H. Appel · 2021 · npj Parkinson s Disease
  33. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson’s disease: A meta-analysis
    Yi Xie, Hongliang Feng, Sisi Peng, Jinsong Xiao, Junjian Zhang · 2016 · Neuroscience Letters
  34. Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease
    Enrico Glaab, Jean‐Pierre Trezzi, Andrea Greuel, Christian Jäger, Zdenka Hodak, Alexander E. Drzezga, Lars Timmermann, Marc Tittgemeyer, Nico J. Diederich, Carsten Eggers · 2019 · Neurobiology of Disease
  35. Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis
    Nadya Pyatigorskaya, Clara Beatriz Sanz-Morère, Rahul Gaurav, Emma Biondetti, Romain Valabrègue, Mathieu David Santin, Lydia Yahia‐Cherif, Stéphane Lehéricy · 2020 · Frontiers in Neurology
  36. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
    Haakon Berven, Simon Ulvenes Kverneng, Erika Sheard, Mona Søgnen, Solveig Amdahl Af Geijerstam, Kristoffer Haugarvoll, Geir Olve Skeie, Christian Dölle, Charalampos Tzoulis · 2023 · Nature Communications
  37. Free-Water Imaging in White and Gray Matter in Parkinson’s Disease
    Christina Andica, Koji Kamagata, Taku Hatano, Asami Saito, Wataru Uchida, Takashi Ogawa, Haruka Takeshige‐Amano, Andrew Zalesky, Akihiko Wada, Michimasa Suzuki et al. · 2019 · Cells
  38. Risk factors of Parkinson disease
    Daniele Belvisi, Roberta Pellicciari, Andrea Fabbrini, Matteo Costanzo, Sara Pietracupa, Maria De Lucia, Nicola Modugno, Francesca Magrinelli, Carlo Dallocchio, Tommaso Ercoli et al. · 2020 · Neurology
  39. Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence
    Valentina Leta, К. Ray Chaudhuri, Oliver Milner, Guy Chung‐Faye, Vinod Metta, Carmine Maria Pariante, Alessandra Borsini · 2021 · Brain Behavior and Immunity
  40. Closing the loop for patients with Parkinson disease: where are we?
    Hazhir Teymourian, Farshad Tehrani, Katherine Longardner, Kuldeep Mahato, Tatiana Podhajny, Jong‐Min Moon, Kotagiri Yugender Goud, Juliane R. Sempionatto, Irene Litvan, Joseph Wang · 2022 · Nature Reviews Neurology
  41. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis
    Dallah Yoo, Ji-In Bang, Choonghyun Ahn, Victoria Nyawira Nyaga, Young‐Eun Kim, Min Ju Kang, Tae‐Beom Ahn · 2022 · Parkinsonism & Related Disorders
  42. Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
    Moritz Ernst, Ann‐Kristin Folkerts, Romina Gollan, Emma Lieker, Julia Caro-Valenzuela, Anne Adams, Nora Cryns, Ina Monsef, Antje Dresen, Mandy Roheger et al. · 2024 · Cochrane Database of Systematic Reviews
  43. The neural exploitation hypothesis and its implications for an embodied approach to language and cognition: Insights from the study of action verbs processing and motor disorders in Parkinson's disease
    Vittorio Gallese M. D, Valentina Cuccio · 2018 · Cortex
  44. Quantitative susceptibility mapping in atypical Parkinsonisms
    Sonia Mazzucchi, Daniela Frosini, Mauro Costagli, Eleonora Del Prete, Graziella Donatelli, Paolo Cipriano Cecchi, Gianmichele Migaleddu, Ubaldo Bonuccelli, Roberto Ceravolo, Mirco Cosottini · 2019 · NeuroImage Clinical
  45. Can infections trigger alpha-synucleinopathies?
    Christopher T. Tulisiak, Gabriela Mercado, Wouter Peelaerts, Lena Brundin, Patrik Brundin · 2019 · Progress in molecular biology and translational science
  46. Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
    Frédérique Depierreux, Éric Parmentier, Laurane Mackels, Katherine Baquero, Christian Degueldre, Evelyne Balteau, Éric Salmon, Christophe L. M. Phillips, Mohamed Ali Bahri, Pierre Maquet et al. · 2021 · npj Parkinson s Disease
  47. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
    Sophie E Mastenbroek, Jacob W. Vogel, Lyduine Eisa Collij, Geidy E. Serrano, Cécilia Tremblay, Alexandra L. Young, Richard A. Arce, Holly A. Shill, Erika D. Driver‐Dunckley, Shyamal H. Mehta et al. · 2024 · Nature Communications
  48. Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level
    Weina Gao, Lingling Pu, Jingyu Wei, Zhanxin Yao, Ya‐Wen Wang, Tala Shi, Liting Zhao, Changya Jiao, Changjiang Guo · 2017 · Diabetes Therapy
  49. Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease
    Helena Bejr‐Kasem, Javier Pagonabarraga, Saül Martínez‐Horta, Frederic Sampedro, Juan Marín‐Lahoz, Andrea Horta‐Barba, Ignacio Aracil‐Bolaños, Jesús Pérez‐Pérez, Maria Angeles Boti, Antònia Campolongo et al. · 2018 · Movement Disorders
  50. Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features
    Shady Rahayel, Ronald B. Postuma, Jacques Yves Montplaisir, Christophe Bedetti, Simona Maria Brambati, Julie Carrier, Oury Monchi, Pierre-Alexandre Bourgouin, Malo Gaubert, Jean‐François Gagnon · 2017 · Cerebral Cortex
  51. Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
    Sebastian Heinzel, Daniela Berg, Sebastian Binder, Georg Ebersbach, Lennart Hickstein, Heinz Herbst, Michael Lorrain, Ingmar Wellach, Walter Maetzler, Gudula Petersen et al. · 2018 · Frontiers in Neurology
  52. MicroRNA-135b alleviates MPP+-mediated Parkinson’s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis
    Rong Zeng, Dixian Luo, Haipeng Li, Qi-Shan Zhang, Shengsuo Lei, Ji-Hua Chen · 2019 · Journal of Clinical Neuroscience
  53. Mechanisms of alpha-synuclein toxicity: An update and outlook
    Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro · 2019 · Progress in brain research
  54. The Spectrum of Sleep Disorders in Parkinson Disease
    Annie Christine Lajoie, Anne‐Louise Lafontaine, Marta Kamińska · 2020 · CHEST Journal
  55. Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases
    Daisy Sproviero, Stella Gagliardi, Susanna Zucca, Maddalena Arigoni, Marta Giannini, Maria Garofalo, Martina Olivero, Michela Dell’Orco, Orietta Pansarasa, Stefano Bernuzzi et al. · 2021 · International Journal of Molecular Sciences
  56. Predicting Parkinson's disease using gradient boosting decision tree models with electroencephalography signals.
    Seung-Bo Lee, Yong-Jeong Kim, Sungeun Hwang, Hyoshin Son, Sang-Kun Lee, Kyung-Il Park, Young-Gon Kim · 2022 · Parkinsonism & Related Disorders
  57. Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment
    Sygrid van der Zee, Prabesh Kanel, Marleen J. J. Gerritsen, Jeffrey M. Boertien, Anne C. Slomp, Martijn L.T.M. Müller, Nicolaas Ida Bohnen, Jacoba Margje Spikman, Teus van Laar · 2022 · Movement Disorders
  58. Parkinson’s Disease is Predominantly a Genetic Disease
    Shen‐Yang Lim, Christine Klein · 2024 · Journal of Parkinson s Disease
  59. Chemosensory dysfunction in neurodegenerative diseases
    2019 · Handbook of Clinical Neurology
  60. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures
    Namyata Pathak- Gandhi, Ashok D. B. Vaidya · 2016 · Journal of Ethnopharmacology
  61. The emerging link between O-GlcNAcylation and neurological disorders
    Xiaofeng Ma, He Li, Yating He, Junwei Hao · 2017 · Cellular and Molecular Life Sciences
  62. The prevalence and associated factors of dysphagia in Parkinson's disease: A systematic review and meta-analysis
    Siyuan Gong, Yan Ling Gao, Jihong Liu, Jia Li, Xueqin Tang, Qian Ran, Rongzhu Tang, Chunlian Liao · 2022 · Frontiers in Neurology
  63. Wearable sensor-based gait analysis to discriminate early Parkinson’s disease from essential tremor
    Shinuan Lin, Chao Gao, Hongxia Li, Pei Huang, Yun Ling, Zhonglue Chen, Kang Ren, Shengdi Chen · 2023 · Journal of Neurology
  64. PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
    Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, Alessandro Michelucci · 2023 · Journal of Neuroinflammation
  65. Recent applications of EEG-based brain-computer-interface in the medical field
    Xiuyun Liu, Wen-Long Wang, Miao Liu, Mingyi Chen, Tânia Pereira, Desta Yakob Doda, Yufeng Ke, Shouyan Wang, Wen Dong, Xiaoguang Tong et al. · 2025 · Military Medical Research
  66. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases
    Tomoya Kon, Masahiko Tomiyama, Koichi Wakabayashi · 2019 · Neuropathology
  67. Mutations in CHCHD2 cause α-synuclein aggregation
    Aya Ikeda, Kenya Nishioka, Hongrui Meng, Masashi Takanashi, Iwao Hasegawa, Tsuyoshi Inoshita, Kahori Shiba‐Fukushima, Yuanzhe Li, Hiroyo Yoshino, Akio Mori et al. · 2019 · Human Molecular Genetics
  68. Cognitive load amplifies Parkinson’s tremor through excitatory network influences onto the thalamus
    Michiel F. Dirkx, Heidemarie Zach, A.J.M. van Nuland, Bastiaan R. Bloem, Ivan Toni, Rick C. G. Helmich · 2020 · Brain
  69. The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension
    Jose‐Alberto Palma, Gabriel Redel‐Traub, Angelo Porciuncula, Daniela Samaniego-Toro, Patricio Millar Vernetti, Yvonne W. Lui, Lucy Norcliffe‐Kaufmann, Horacio Kaufmann · 2020 · Parkinsonism & Related Disorders
  70. Deep Learning Identifies Digital Biomarkers for Self-Reported Parkinson's Disease
    Hanrui Zhang, Kaiwen Deng, Hongyang Li, Roger L. Albin, Yuanfang Guan · 2020 · Patterns
  71. Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences
    Charysse Vandendriessche, Arnout Bruggeman, Caroline Van Cauwenberghe, Roosmarijn E. Vandenbroucke · 2020 · Cells
  72. Art therapy for Parkinson's disease
    Alberto Cucca, Alessandro Di Rocco, Ikuko Acosta, Mahya Beheshti, Marygrace Berberian, Hilary C. Bertisch, Amgad Droby, Tom Ettinger, Todd E. Hudson, Matilde Inglese et al. · 2021 · Parkinsonism & Related Disorders
  73. The role of amyloids in Alzheimer's and Parkinson's diseases
    Parveen Salahuddin, Munazza Tamkeen Fatima, Vladimir Nikolaevich Uversky, Rizwan Hasan Khan, Zeyaul Islam, Mohammad Furkan · 2021 · International Journal of Biological Macromolecules
  74. Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
    Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, Christina Piperi · 2022 · Brain Sciences
  75. Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson’s disease in Chinese population
    Hongxu Pan, Zhenhua Liu, Jinghong Ma, Yuanyuan Li, Yuwen Zhao, Xiaoxia Zhou, Yaqin Xiang, Yige Wang, Xun Clare Zhou, Runcheng He et al. · 2023 · npj Parkinson s Disease
  76. Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease
    Rainer von Coelln, Lisa M. Shulman · 2016 · Current Opinion in Neurology
  77. Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample
    Petra Tomše, Luka Jensterle, Marko Grmek, Katja Zaletel, Zvezdan Pirtošek, VIJAY M. DHAWAN, Shichun Peng, David Eidelberg, Yilong Ma, Maja Trošt · 2017 · Neuroradiology
  78. Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism
    Sirwan K.L. Darweesh, Frank J. Wolters, Ronald B. Postuma, Bruno H. Ch. Stricker, Albert Hofman D, Peter J. Koudstaal, M. Kamran Ikram, M. Arfan Ikram · 2017 · JAMA Neurology
  79. Cognitive and motor dual task gait training exerted specific training effects on dual task gait performance in individuals with Parkinson’s disease: A randomized controlled pilot study
    Yea‐Ru Yang, Shih‐Jung Cheng, Yu-Ju Lee, Yan-Ci Liu, Ray‐Yau Wang · 2019 · PLoS ONE
  80. NOTCH2NLC Intermediate‐Length Repeat Expansions Are Associated with Parkinson Disease
    Changhe Shi, Yu Fan, Jing Yang, Yanpeng Yuan, Si Shen, Fen Liu, Chengyuan Mao, Han Liu, Shuo Zhang, Zheng‐wei Hu et al. · 2020 · Annals of Neurology
  81. Extracellular vesicles – propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases
    Natasha Vassileff, Lesley Cheng, Andrew Francis Hill · 2020 · Journal of Cell Science
  82. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease
    Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer Nathan Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial, Hervé Bercovier · 2021 · Vaccines
  83. Defining Speech Subtypes in De Novo Parkinson Disease
    Jan Rusz, Tereza Tykalová, Michal Novotný, David Zogala, Karel Šonka, Evžen Růžička, Petr Dušek · 2021 · Neurology
  84. Epidemiology of Parkinson’s Disease: An Update
    Juan R. Deliz, Caroline M. Tanner, Paulina González-Latapí · 2024 · Current Neurology and Neuroscience Reports
  85. MDS clinical diagnostic criteria for Parkinson’s disease in China
    Jun Li, Miao Jin, Li Wang, Bin Qin, Kang Wang · 2016 · Journal of Neurology
  86. Neuroprotective effect of naringenin against MPTP-induced oxidative stress
    Mani Sugumar, Murugan Sevanan, S. Sekar · 2018 · International Journal of Neuroscience
  87. Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
    Stefanie Smolders, Christine Van Broeckhoven · 2020 · Acta Neuropathologica Communications
  88. Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson's Disease
    Christopher Fugl Madelung, David Meder, Søren A. Fuglsang, Marta M. Marques, Vincent O. Boer, Kristoffer Hougaard Madsen, Esben Thade Petersen, Anne‐Mette Hejl, Annemette Løkkegaard, Hartwig Roman Siebner · 2022 · Movement Disorders
  89. Prodromal Parkinson's disease: hype or hope for disease-modification trials?
    P. Mahlknecht, Kathrin Marini, M. Werkmann, W. Poewe, K. Seppi · 2022 · Translational Neurodegeneration
  90. Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study
    Junyu Lin, Ruwei Ou, Chunyu Li, Yanbing Hou, Lingyu Zhang, Qianqian Wei, Dejiang Pang, Kuncheng Liu, Qirui Jiang, Tianmi Yang et al. · 2023 · BMC Medicine
  91. L‐ DOPA for Parkinson's disease—a bittersweet pill
    Emma L. Lane · 2018 · European Journal of Neuroscience
  92. Abnormal Cerebellar Connectivity Patterns in Patients with Parkinson’s Disease and Freezing of Gait
    Komal Bharti, Antonio Suppa, Sara Pietracupa, Neeraj Upadhyay, Costanza Giannì, Giorgio Leodori, Francesca Di Biasio, Nicola Modugno, Nikolaos Petsas, Giovanni Grillea et al. · 2018 · The Cerebellum
  93. Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study
    Michèle Tinazzi, Marialuisa Gandolfi, Roberto Ceravolo, Marianna Capecci, Elisa Andrenelli, Maria Gabriella Ceravolo, Laura Bonanni, MARCO C. ONOFRJ, Michela Vitale, Mauro Catalan et al. · 2019 · Movement Disorders Clinical Practice
  94. The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
    Dennison Trinh, Ahmad R. Israwi, Lindsay R. Arathoon, Jacqueline A. Gleave, Joanne E. Nash · 2020 · Journal of Neurochemistry
  95. Wearables in the home-based assessment of abnormal movements in Parkinson’s disease: a systematic review of the literature
    Stefania Ancona, Francesca Dalia Faraci, Elina Khattab, Luigi Fiorillo, Oriella Gnarra, Tobias Nef, Claudio L. Bassetti, Panagiotis Bargiotas · 2021 · Journal of Neurology
  96. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder
    Liche Zhou, Guanglu Li, Yuyao Zhang, Miao Zhang, Zhichun Chen, Lina Zhang, Xiaojin Wang, Ming Zhang, Guanyu Ye, Yuanyuan Li et al. · 2021 · Brain
  97. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases
    Rahel Feleke, Regina Hertfelder Reynolds, Amy M. Smith, Bension Shlomo Tilley, Sarah A. Gagliano Taliun, John Hardy, Paul McMahan Matthews, Steve Gentleman, David R. Owen, Michael R. Johnson et al. · 2021 · Acta Neuropathologica
  98. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study
    Ida Manna, Andrea Quattrone, Selene De Benedittis, Basilio Vescio, Enrico Iaccino, Aldo Quattrone · 2021 · Parkinsonism & Related Disorders
  99. Applications of nanobodies in brain diseases
    Fang Zheng, Yucheng Pang, Luyao Li, Yuxing Pang, Jiaxin Zhang, Xinyi Wang, Geert Raes · 2022 · Frontiers in Immunology
  100. Parkinson’s Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care
    Uduak Effiong Williams, Oliver Bandmann, Richard William Walker · 2018 · Journal of Movement Disorders